Entries by Healthcare Team

TECregen Appoints Drug Development Veteran Dr. Klaas P. Zuideveld as Chief Executive Officer to Lead Thymus Regeneration Platform into Clinical Development

/in

Appointment builds on CHF 10 million seed financing and Board leadership expansion Basel, Switzerland, January 29, 2026 – TECregen, a biotechnology company pioneering thymus rejuvenation, today announced the appointment of Dr. Klaas P. Zuideveld, Ph.D., as Chief Executive Officer (CEO). Dr. Zuideveld will lead TECregen’s strategy and execution as the company advances its thymopoietic biologics designed to rejuvenate […]

Biocomposites launches SYNICEM™ spacers in Canada

/in

Ready-to-use preformed antibiotic loaded spacers for hip, knee and shoulder revisions Choice of Charnley and Müller hip spacer designs, and left and right geometries for each knee Keele, UK, 29 January 2026 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft […]

ViCentra Appoints Diabetes Commercialization Leader Reman McDonagh as Vice President, Global Marketing

/in

Marketing executive brings 20+ years of global diabetes experience to support European scale-up and next-generation Kaleido launch readiness Utrecht, the Netherlands — January 29, 2026 ViCentra, a European medical device company commercializing the Kaleido insulin patch pump system, announced today that Reman McDonagh, PhD, has joined the Company as Vice President, Global Marketing. McDonagh’s appointment […]

Hansa Biopharma to host Year-end report 2025 conference call

/in

Lund, Sweden, 26 January, 2026. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), will publish its year-end report for January – December 2025 on Wednesday 11 February, 2026. Interested parties may join the Company’s quarterly conference call on the same date at 14:00 CET / 8:00 AM EST. The event will be hosted by Renée Aguiar-Lucander, CEO, Evan Ballantyne, CFO, […]

© Optimum Strategic Communications.